Diligent Investors’s DexCom DXCM Stock Holding History

Diligent Investors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,800	Closed	-$218K	–	365
2024 Q4	$218K	Buy	+2,800	New	+$207K	0.05%	339

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Diligent Investors's DXCM Position: Q1 2025 in Review

Diligent Investors sold out of DexCom (DXCM) in Q1 2025, closing a stake of 2,800 shares — an estimated $218K sold.

Diligent Investors first reported a position in DXCM in Q4 2024 and held it in 1 quarter. The position peaked at $218K in Q4 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

Diligent Investors reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
Diligent Investors sold 2,800 DexCom shares in Q1 2025, an estimated $218K.
Diligent Investors first reported a position in DexCom in Q4 2024 and held it in 1 quarter.
Diligent Investors's DexCom position peaked at $218K in Q4 2024.
932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Diligent Investors's 13F filing for Q1 2025, filed 10 Apr 2025.